Medical device giant Covidien has acquired sports and medical wearables company Zephyr Technology, which previous investors included 3M New Ventures, Alsop Louie Partners and Motorola Solutions Venture Capital.
Neither Covidien nor Zephyr has announced the deal, and we got to learn about it from MobiHealthNews.
Zephyr makes few wearable products, including BioHarness and BioPatch. The former is an FDA-approved wearable chest strap that monitors heart rate, breathing rate, ECG and posture; while the latter is a bandaid-like sensor which has similar capabilities and is supported by companion software called ZephyrLife.
The company’s products have been used by few high-profile users such as football, MLB and NBA players; Formula 1 drivers; and even CNN’s Chief Medical Correspondent Sanjay Gupta. While Zephyr was still developing its technology, their products have been tested by NASA, the Department of Defense, and the Department of Homeland Security.